Atlas Trials

Laekna Limited

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Laekna Limited

RecordFirmDate
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants (NCT07230496)Laekna Limited2025-12-30
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women (NCT06908707)Laekna Limited2025-04-22
Human Mass Balance and Biotransformation Study of [14C]Afuresertib (NCT05489744)Laekna Limited2022-08-06
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 (NCT05383482)Laekna Limited2022-07-01
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer (NCT04851613)Laekna Limited2022-02-18
PhI to Solid Tumors and PhII to Locally Advanced or mTNBC (NCT05390710)Laekna Limited2021-06-12
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (NCT04374630)Laekna Limited2020-06-09
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC (NCT04060394)Laekna Limited2019-09-13
A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer (NCT03843918)Laekna Limited2019-04-05

Track Laekna Limited automatically

Every clearance here is in the API, with alerts when new ones post.